ARK Genomic Revolution ETF (BATS:ARKG) Shares Sold by Sierra Capital LLC

Sierra Capital LLC cut its holdings in ARK Genomic Revolution ETF (BATS:ARKG) by 32.3% during the fourth quarter, Holdings Channel reports. The institutional investor owned 12,636 shares of the company’s stock after selling 6,035 shares during the quarter. Sierra Capital LLC’s holdings in ARK Genomic Revolution ETF were worth $298,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently bought and sold shares of ARKG. Rothschild Investment LLC lifted its holdings in ARK Genomic Revolution ETF by 15.2% in the fourth quarter. Rothschild Investment LLC now owns 15,150 shares of the company’s stock valued at $357,000 after acquiring an additional 2,000 shares during the period. Union Bancaire Privee UBP SA purchased a new position in shares of ARK Genomic Revolution ETF in the fourth quarter valued at $45,000. Atria Wealth Solutions Inc. increased its position in shares of ARK Genomic Revolution ETF by 121.1% in the fourth quarter. Atria Wealth Solutions Inc. now owns 19,792 shares of the company’s stock valued at $466,000 after buying an additional 10,841 shares in the last quarter. Sanctuary Advisors LLC acquired a new position in shares of ARK Genomic Revolution ETF during the 4th quarter worth $401,000. Finally, Hemington Wealth Management boosted its position in shares of ARK Genomic Revolution ETF by 44.6% in the 4th quarter. Hemington Wealth Management now owns 1,310 shares of the company’s stock worth $30,000 after buying an additional 404 shares in the last quarter.

ARK Genomic Revolution ETF Stock Up 12.3 %

BATS:ARKG opened at $26.51 on Tuesday. The company’s fifty day simple moving average is $25.87 and its 200-day simple moving average is $25.40.

ARK Genomic Revolution ETF Profile

The ARK Genomic Revolution ETF (ARKG) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund that targets companies involved in the genomics industry. ARKG was launched on Oct 31, 2014 and is managed by ARK.